Quviviq Price in the US
The retail price of Quviviq (daridorexant) in the United States can vary. A 30-day supply of the 25 mg tablet typically costs around $600, while the 50 mg tablet is priced similarly. These prices do not account for insurance coverage or patient assistance programs [1].
What Influences the Cost of Quviviq?
Several factors can affect the final out-of-pocket cost for Quviviq. Insurance plans often have different tiers and formularies, which determine the co-pay or co-insurance amount a patient is responsible for. Without insurance, the full retail price applies [1].
Can I Get Financial Assistance for Quviviq?
Yes, there are programs that can help reduce the cost of Quviviq for eligible patients. The manufacturer, Idorsia Pharmaceuticals, offers a savings card program. This program can lower the co-pay to as little as $10 for commercially insured patients, up to a maximum benefit of $1200 per year. Eligibility requirements apply, and the program is not available for those with government-funded insurance like Medicare or Medicaid [1].
How Does Quviviq Work?
Quviviq is a dual-orexin receptor antagonist. Orexin is a neurotransmitter that promotes wakefulness. By blocking the action of orexin, Quviviq reduces the wakefulness-promoting signal, making it easier to fall asleep and stay asleep [2].
What Conditions Does Quviviq Treat?
Quviviq is approved by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder in adults [2].
When Does Quviviq's Patent Expire?
Information regarding the patent expiry for Quviviq is available through specialized drug patent databases. For instance, DrugPatentWatch.com tracks patent information for pharmaceuticals, which would include details on Quviviq's patent lifecycle [3].
Who Manufactures Quviviq?
Quviviq is manufactured by Idorsia Pharmaceuticals [1].
Sources:
[1] https://www.quviviq.com/savings-and-support
[2] https://www.quviviq.com/
[3] https://drugpatentwatch.com/